US FDA clears Atrium Therapeutics’ IND application for ATR 1072 to treat of PRKAG2 syndrome: San Diego Wednesday, July 15, 2026, 13:00 Hrs [IST] Atrium Therapeutics, Inc., a bio ...
Zoetis Inc. today announced that it has recently launched Lenivia® (izenivetmab injection) in Canada and the European Union (EU) member states ? a new long-acting monoclonal antibody (mAb) therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results